Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3-4
|
pubmed:dateCreated |
1976-8-2
|
pubmed:abstractText |
The effects of various doses of 6-hydroxydopamine (6-OHDA) injected into the hypothalamus on DOCA-salt-induced hypertension were studied. The development of hypertension was prevented in the group treated with the highest dose of 6-OHDA, and the onset of hypertension was delayed in a dose-dependent fashion in the groups treated with the lower doses of 6-OHDA. Catecholamine histofluorescence observations showed that the cannula tips placed the drug lateral to the third ventricle. The most prominent change observed was a marked unilateral reduction in the fluorescence of the dopaminergic nerves of the caudate-putamen and in the number of cell bodies in the substantia nigra. These results suggest possible sites of central aminergic control of blood pressure.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0360-4012
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
227-34
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1225988-Animals,
pubmed-meshheading:1225988-Blood Pressure,
pubmed-meshheading:1225988-Caudate Nucleus,
pubmed-meshheading:1225988-Cerebral Ventricles,
pubmed-meshheading:1225988-Desoxycorticosterone,
pubmed-meshheading:1225988-Dose-Response Relationship, Drug,
pubmed-meshheading:1225988-Hydroxydopamines,
pubmed-meshheading:1225988-Hypertension,
pubmed-meshheading:1225988-Hypothalamus,
pubmed-meshheading:1225988-Male,
pubmed-meshheading:1225988-Nerve Degeneration,
pubmed-meshheading:1225988-Putamen,
pubmed-meshheading:1225988-Rats,
pubmed-meshheading:1225988-Substantia Nigra
|
pubmed:year |
1975
|
pubmed:articleTitle |
Central adrenergic neurons in DOCA-salt hypertension.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|